The effect of food on tramadol and celecoxib bioavailability following oral administration of Co-Crystal of Tramadol-Celecoxib (CTC): a randomised, open label, single-dose, crossover study in healthy volunteers

dc.contributor.author
Encina, Gregorio
dc.contributor.author
Encabo, Mercedes
dc.contributor.author
Escriche, Marisol
dc.contributor.author
Lahjou, Mounia
dc.contributor.author
Sicard, Eric
dc.contributor.author
Smith, Kevin
dc.contributor.author
Gascón, Neus
dc.contributor.author
Plata Salamán, Carlos
dc.contributor.author
Videla, Sebastià
dc.date.issued
2020-11-24T13:25:43Z
dc.date.issued
2020-11-24T13:25:43Z
dc.date.issued
2018
dc.date.issued
2020-11-24T13:25:43Z
dc.identifier
1173-2563
dc.identifier
https://hdl.handle.net/2445/172304
dc.identifier
697976
dc.identifier
30008052
dc.description.abstract
ackground and Objective Co-Crystal of Tramadol-Celecoxib (CTC), in development for the treatment of moderate to severe acute pain, is a first-in-class co-crystal containing a 1:1 molecular ratio of two active pharmaceutical ingredients; rac- tramadol·HCl and celecoxib. This randomised, open-label, crossover study compared the bioavailability of both components after CTC administration under fed and fasting conditions. Methods Healthy adults received single doses of 200 mg CTC under both fed and fasting conditions (separated by a 7-day washout). Each dose of CTC was administered orally as two 100 mg tablets, each containing 44 mg tramadol·HCl and 56 mg celecoxib. In the fed condition, a high-fat, high-calorie meal [in line with recommendations by the US Food and Drug Administration (FDA)] was served 30 min before CTC administration. Tramadol, O-desmethyltramadol and celecoxib plasma concentrations were measured pre- and post-dose up to 48 h. Pharmacokinetic parameters were calculated using non-compartmental analysis. Safety was also assessed. Results Thirty-six subjects (18 female/18 male) received one or both doses of CTC; 33 provided evaluable pharmacokinetic data under fed and fasting conditions. For tramadol and O-desmethyltramadol, fed-to-fasting ratios of geometric least-squares means and corresponding 90% confidence interval (CI) values for maximum plasma concentration (Cmax) and extrapolated area under the plasma concentration-time curve to infinity (AUC∞) were within the pre-defined range for comparative bio- availability (80-125%). For celecoxib, Cmax and AUC∞ fed-to-fasting ratios (90% CIs) were outside this range, at 130.91% (116.98-146.49) and 129.34% (121.78-137.38), respectively. The safety profile of CTC was similar in fed and fasting conditions. Conclusions As reported for standard-formulation celecoxib, food increased the bioavailability of celecoxib from single-dose CTC. Food had no effect on tramadol or O-desmethyltramadol bioavailability.
dc.format
9 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
Springer Nature
dc.relation
Reproducció del document publicat a: https://doi.org/10.1007/s40261-018-0672-y
dc.relation
Clinical Drug Investigation, 2018, vol. 38, num. 9, p. 819-827
dc.relation
https://doi.org/10.1007/s40261-018-0672-y
dc.rights
cc by-nc (c) Springer Nature, 2018
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Tractament del dolor
dc.subject
Analgèsics
dc.subject
Opiacis
dc.subject
Pain treatment
dc.subject
Analgesics
dc.subject
Opioids
dc.title
The effect of food on tramadol and celecoxib bioavailability following oral administration of Co-Crystal of Tramadol-Celecoxib (CTC): a randomised, open label, single-dose, crossover study in healthy volunteers
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.